Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.26 USD | -2.89% | -1.28% | -11.41% |
Apr. 22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
Mar. 28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.41% | 3.33B | |
+4.16% | 32.41B | |
+12.62% | 7.31B | |
+20.71% | 3.85B | |
-27.11% | 1.26B | |
-34.31% | 1.12B | |
+4.25% | 932M | |
-23.45% | 864M | |
-38.17% | 863M | |
-18.08% | 702M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Evolent Health : Adjusted Loss Edges Higher in Q2; Raises FY21 Revenue Guidance